NTLA insiders

17 insiders have filed at NTLA since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.

namerolereported stake% of companybuys (3y)sells (3y)
Leonard John MPresident And CEO1.23M1.037%6 sells $2.0M
Cohen Fred EDirector207.5k0.175%1 buys $1.4M
Dulac Edward J IIIEVP, Chief Financial Officer161.0k0.136%2 sells $163k
Basta JamesEVP, General Counsel156.8k0.132%6 sells $410k
Schultes Birgit CEVP, Chief Scientific Officer137.7k0.116%2 sells $79k
Chase William JDirector134.7k0.114%1 buys $1.0M
Lebwohl DavidEVP, Chief Medical Officer131.2k0.111%3 sells $398k
Clark ElianaEVP, Chief Technical Officer93.9k0.079%11 sells $389k
Sepp-Lorenzino LauraEVP, Chief Scientific Officer77.4k0.065%4 sells $338k
Dube Michael PVP, Chief Accounting Officer69.5k0.059%5 sells $140k
Goddard GlennEVP, Chief Financial Officer69.2k0.058%1 sells $158k
Hicks DerekEVP, Chief Business Officer59.9k0.051%2 sells $193k
Keresty GeorgiaDirector31.9k0.027%
Bhanji MunaDirector27.2k0.023%5 sells $96k
Verwiel FrankDirector25.9k0.022%1 sells $38k
Goodman JesseDirector24.4k0.021%2 sells $29k
Goff BrianDirector23.4k0.02%

Full register at boothcheck.com/insiders/NTLA. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.

NTLA institutional holders · NTLA research report